In short, we found that CLP36 expression correlates with the prognosis of lymphoma patients and that silencing CLP36 expression leads to reduced proliferative capacity and increased apoptosis of lymphoma cells, which correlates with inhibition of the CLP36/PI3K/AKT/CREB axis. This evidence concerns the gene CREB1 and lymphoma.